SARS-CoV-2 Spike receptor binding domain, RBD (513-520) – Lys(Biotin-LC) – 0.1 mg

Overview

Introducing the SARS-CoV-2 Spike receptor binding domain (RBD) peptide, specifically the sequence for residues 513-520, which is essential for studying the virus’s interaction with host cells. This peptide is labeled with Biotin-LC at the C-terminus, making it incredibly useful for a variety of applications in research and diagnostics. Ideal for your assays and experiments, this peptide helps facilitate detection and further biological studies of the SARS-CoV-2 spike protein.

Key Features

• Sequence: Covers residues 513-520 of the SARS-CoV-2 RBD
• Biotinylated at the C-terminus for easy detection
• Facilitates studies on virus receptor interactions
• Useful for various immunochemical applications
• High-purity, reliable performance for your laboratory needs

Specifications

FAQ

What applications can I use this peptide for?

This peptide is ideal for assays related to SARS-CoV-2, including receptor binding studies, antibody interaction tests, and various immunodetection methods.

Is this peptide suitable for use in vivo?

While this peptide is primarily designed for in vitro studies, consult specific literature or product guidelines regarding potential in vivo applications.

How should I store the peptide?

For optimal stability, store the peptide at -20°C and avoid repeated freeze-thaw cycles.

The SARS-CoV-2 Spike receptor binding domain peptide is a vital addition to your research toolkit. With its precise sequence and biotin labeling, you can confidently explore the mechanisms of viral entry and develop effective assays. Shop now and ensure your experiments yield reliable and meaningful results.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.